Bombay Oxygen posts FY26 net loss, declares dividend

2 min read     Updated on 27 May 2026, 05:04 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Bombay Oxygen Investments Limited reported a net loss of ₹324.06 crore for FY26, a sharp reversal from the net profit of ₹1,750.59 crore in FY25, primarily due to a net loss of ₹467.82 crore on fair value changes of financial assets. Total income turned negative at ₹182.43 crore. Despite the loss, the board recommended a dividend of ₹25 per equity share of ₹100 each, subject to shareholder approval. The company fixed August 18, 2026, as the record date for the dividend and the 65th Annual General Meeting.

powered bylight_fuzz_icon
41423946

*this image is generated using AI for illustrative purposes only.

Bombay Oxygen Investments Limited reported a net loss of ₹324.06 crore for the financial year ended March 31, 2026, reversing the net profit of ₹1,750.59 crore achieved in the previous year. The company’s financial performance was heavily impacted by a net loss on fair value changes of financial assets, which totaled ₹467.82 crore for the year. Despite the loss, the Board of Directors has recommended a dividend of ₹25 per equity share of ₹100 each, pending approval by shareholders at the ensuing Annual General Meeting.

The audited financial results, approved by the board on May 27, 2026, reveal that total income for the year turned negative at ₹182.43 crore, compared to a positive total income of ₹2,090.39 crore in FY25. Dividend income for the year increased to ₹271.43 crore from ₹226.52 crore in the prior year. Total expenses rose to ₹205.01 crore from ₹182.74 crore in the previous year, primarily due to higher other expenses.

For the quarter ended March 31, 2026, the company reported a net loss of ₹3,140.75 crore, a sharp increase from the net loss of ₹1,230.14 crore in the corresponding quarter of the previous year. Total income for the quarter was a negative ₹3,541.48 crore, largely due to a net loss on fair value changes of financial assets of ₹3,565.12 crore during the period.

Financial Results for FY26

The following table outlines the key financial metrics for the year ended March 31, 2026, compared to the prior year:

Particulars Year Ended 31.03.2026 (₹ in Lakhs) Year Ended 31.03.2025 (₹ in Lakhs)
Revenue from Operations
Dividend Income 271.43 226.52
Net gain/(loss) on fair value changes (467.82) 1,794.79
Other Income 13.96 69.08
Total Income (182.43) 2,090.39
Total Expenses 205.01 182.74
Profit/(Loss) before tax (387.44) 1,907.65
Net Profit/(Loss) for the year (324.06) 1,750.59

Balance Sheet Highlights

As of March 31, 2026, the company's total assets stood at ₹4,962.12 crore, a decrease from ₹5,089.22 crore in the previous year. Investments constituted the largest portion of assets at ₹4,883.92 crore, down from ₹5,008.25 crore in FY25. Total equity decreased to ₹4,726.26 crore from ₹4,830.73 crore, while other equity stood at ₹4,711.26 crore.

Corporate Actions

The Board has fixed Tuesday, August 18, 2026, as the record date to determine shareholders eligible for the final dividend and the Annual General Meeting. The register of members will remain closed from August 19, 2026, to August 25, 2026. The 65th Annual General Meeting is scheduled for August 25, 2026, via video conferencing. The Independent Auditor's Report for the financial results is free from qualifications.

Historical Stock Returns for Bombay Oxygen

1 Day5 Days1 Month6 Months1 Year5 Years
-3.52%-6.07%-9.00%-16.89%-23.54%+40.58%

How will shareholders react to the recommended dividend given the significant net loss and decline in total income?

What strategies will the company employ to mitigate the volatility in fair value changes of financial assets moving forward?

Will the company adjust its investment portfolio composition to reduce exposure to high-risk assets following this year's losses?

Bombay Oxygen Investments Limited Schedules Board Meeting on May 27, 2026 to Consider Q4FY26 Results and Dividend

1 min read     Updated on 19 May 2026, 03:50 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Bombay Oxygen Investments Limited has informed BSE of a Board of Directors meeting on May 27, 2026, under Regulation 29 of SEBI Listing Regulations, to consider audited standalone financial results for the quarter and financial year ended March 31, 2026, and to recommend dividend, if any. The Trading Window for designated persons has been closed from April 1, 2026, to May 29, 2026, inclusive.

powered bylight_fuzz_icon
40731190

*this image is generated using AI for illustrative purposes only.

Bombay Oxygen Investments Limited has notified BSE of an upcoming Board of Directors meeting, scheduled for Wednesday, May 27, 2026. The intimation was made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The Board meeting has been convened to consider and approve key financial and corporate matters pertaining to the financial year ended March 31, 2026. The following items are on the agenda:

Agenda Item: Details
Financial Results: Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026
Dividend Recommendation: Recommendation of dividend, if any, on equity shares for the financial year ended March 31, 2026
Meeting Date: Wednesday, May 27, 2026

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and the company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, Bombay Oxygen Investments Limited has closed its Trading Window for all designated persons and their immediate relatives. The closure is effective from April 1, 2026, to May 29, 2026, both days inclusive.

The intimation was signed by Anshika Pal, Company Secretary and Compliance Officer, on May 19, 2026.

Historical Stock Returns for Bombay Oxygen

1 Day5 Days1 Month6 Months1 Year5 Years
-3.52%-6.07%-9.00%-16.89%-23.54%+40.58%

How does Bombay Oxygen Investments Limited's dividend payout history trend, and what yield might investors expect for FY2026 given the company's recent financial performance?

How have Bombay Oxygen Investments Limited's standalone financial results trended over the past three fiscal years, and what key metrics should investors watch for in the FY2026 results?

Could any strategic corporate actions, such as acquisitions, restructuring, or capital allocation changes, be announced alongside the FY2026 financial results at the May 27 board meeting?

More News on Bombay Oxygen

1 Year Returns:-23.54%